WCD 2019 Distinguished Lectureship Speakers Announced

[ric id="2579" srcmoduleimage="https://ilds.org/wp-content/uploads/2018/07/WCD2019-speakers-360x260.jpg" srcsquare="https://ilds.org/wp-content/uploads/2018/07/WCD2019-speakers-360x354.jpg" srcoriginal="https://ilds.org/wp-content/uploads/2018/07/WCD2019-speakers-450x84.jpg" srcvideo="https://ilds.org/wp-content/uploads/2018/07/WCD2019-speakers-320x180.jpg" srcnarrow="https://ilds.org/wp-content/uploads/2018/07/WCD2019-speakers-475x100.jpg" format="original" alt="" caption="Thomas Boller, Elena Cattaneo, John O'Shea, Paul Redmond and Yoshimori Tamotsu" classes="center"] Thomas Boller - the Beginning and End of the Universe Prof Dr Thomas Boller has worked at the Max-Planck Institut für Extraterrestrische Physik (MPE) in Garching since 1990. His main research interests include Active Galactic Nuclei. During his time at MPE he has discovered the importance of Narrow-Line Seyfert 1 Galaxies for the study of active galaxies resulting in an improved understanding of several problems raised by the Seyfert phenomenon. He lectures on all Astrophysics courses at the Johann Wolfgang Goethe-Universität in Frankfurt. Prof Boller is a member of the international Sloan-Collaboration, the XMM Survey Science Consortium and the XEUS Astrophysical working groups and has been awarded the Michael and Biserka Baum Preis Award for his outstanding research on Active Galactic Nuclei. Elena Cattaneo - Neural stem cells and their potential application Prof Elena Cattaneo is an Italian pharmacologist and co-founding director of the University of Milan's Center for Stem Cell Research. The main research theme of her lab is neural stem cells and the molecular pathophysiology of Huntington’s Disease, for which she has been awarded the “Le Scienze” Price for Medicine and a Gold Medal from the President of the Italian Republic in 2001. In 2005 she was awarded the Marisa Bellisario and Chiara D’Onofrio prizes, in 2006 was nominated Cavaliere Ufficiale (Knight) of the Italian Republic, and in 2013 was appointed a senator for life by Italy's president, Giorgio Napolitano. John O'Shea - Immunology and the Jak/STAT pathway Dr John J. O'Shea started his own research group at the National Cancer Institute in 1989 and then moved to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) in 1994 as Chief of the Lymphocyte Cell Biology Section of the Arthritis and Rheumatism Branch. He was appointed Chief of the Molecular Immunology and Inflammation Branch in 2002 and became Scientific Director and Director of the NIAMS Intramural Research Program in 2005. Dr O’Shea also served as Acting Director of the NIH Center for Regenerative Medicine from 2009-2011. Dr O'Shea has received a number of awards and he has been the recipient of the National Institutes of Health Director's Award three times (1998, 2008, 2010). Paul Redmond - Millennials and Generation X Dr Paul Redmond is the Director of Student Experience and Enhancement at the University of Liverpool and an expert on generations and the world of work. As an experienced writer and speaker, Dr Redmond has presented at numerous events and conferences around the world. In addition to writing regularly for national newspapers, he is a frequent contributor to radio and TV programmes. His work brings him into contact with a broad range of national and international organisations. His research into the future of work and ‘Generation Y’ has attracted considerable attention among both graduate recruiters and the media. Tamotsu Yoshimori - Autophagy Dr. Tamotsu Yoshimori received his PhD degree in 1989 at Osaka University. After working at several places including the European Molecular Biology Laboratory (Prof Kai Simons lab) and National Institute of Basic Biology (Prof Yoshinori Ohsumi lab), he is now a distinguished professor of Osaka University (Graduate School of Medicine and of Frontier Biosciences) and a director of Research Center for Autophagy, Osaka University. His research interests are focused on intracellular membrane trafficking, and especially for the last 21 years, autophagy. He started his study on mammalian autophagy in the lab of Prof Yoshinori Ohsumi, a pioneer in the field who received Nobel Prize in Physiology or Medicine in 2016. Yoshimori identified LC3 as an autophagosome binding protein, which has been widely used as the gold standard in autophagy assays. He also provided new insights into membrane biogenesis in autophagy and the role of autophagy in pathogen defence and suppression of various diseases. Register now to the World Congress of Dermatology, Milan, 10-15 June 2019